Bright Minds Biosciences Inc.
DRUG · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $82,909 | $5,720 | $6,748 | $11,628 |
| Short-Term Investments | $62 | $0 | $0 | $0 |
| Receivables | $413 | $50 | $0 | $156 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $84,310 | $5,987 | $6,813 | $11,948 |
| Property Plant & Equip (Net) | $80 | $118 | $66 | $139 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $32 | $0 | $0 | -$0 |
| Total NC Assets | $112 | $118 | $66 | $139 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $84,422 | $6,105 | $6,879 | $12,087 |
| Liabilities | – | – | – | – |
| Payables | $1,710 | $408 | $182 | $1,246 |
| Short-Term Debt | $61 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | -$61 | $0 | $0 | $0 |
| Total Curr. Liab. | $2,335 | $529 | $281 | $1,472 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $41 | $40 | $0 | $72 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $126 | $119 | $74 | $140 |
| Total Liabilities | $2,377 | $568 | $281 | $1,544 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $88,493 | $35,423 | $33,914 | $32,238 |
| Retained Earnings | -$33,443 | -$34,349 | -$31,547 | -$24,175 |
| AOCI | $3,858 | $4,006 | $3,399 | $2,479 |
| Other Equity | $0 | $456 | $832 | $0 |
| Total Equity | $58,908 | $5,536 | $6,598 | $10,543 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $60,615 | $6,105 | $6,879 | $12,087 |
| Net Debt | -$82,848 | -$5,720 | -$6,748 | -$11,628 |